Latest news
IPM Brief – Issue 14 | The Shortcut Is Not the Pathway
By Denis Horgan
England Moved the Vaccine Clock. The Coverage Gap Stayed Put
Resistant hypertension may need a diagnostic revolution, not just another drug
When diabetes tech fails, personalised care fails with it
IPM Brief – Issue 7 | The Gate Is the Product
AI genomics market set to hit $9.3B by 2030, but regulation and equity gaps remain unresolved
Japan Approves MRD Testing. Price Will Decide Whether Patients Can Use It.
MS Does Not End at the Clinic Door. It Follows People Into Work, Money and Relationships.
For Drug-Resistant Epilepsy, Surgery Should Not Be the Only Door
Diphtheria Came Back. Remote Communities Are Carrying the Cost.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.